The personalized Genomics Market was valued at USD 11.0 Billion in 2022 and is expected to reach USD 28.14 Billion in 2032 registering a CAGR of 11% during the forecast period. The increased need for personalized treatment, the prevalence of chronic diseases, and the development of genomics technology are the main factors driving the market expansion. Personalizing medical...